Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1986-01-21
1988-06-14
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 46, 514218, 514258, 514264, 514307, 514455, 514573, A61K 3150, A61K 3170, A61K 3151, A61K 31505, A61K 3152, A61K 3147, A61K 3145, A61K 3119
Patent
active
047512245
ABSTRACT:
A method for reducing the incidence of metastasis in tumor victims without treating the primary tumor per se resides in the administration of forskolin or its analogs which are potent inhibitors of platelet aggregation. Forskolin compounds are generally defined as labdane diterpenoids having the general formula: ##STR1## These compounds may be administered alone or in combination with other inhibitors of platelet aggregation.
REFERENCES:
patent: 4088659 (1978-05-01), Bhat et al.
patent: 4118508 (1978-10-01), Bhat et al.
patent: 4134986 (1979-01-01), Bajwa et al.
patent: 4476140 (1984-10-01), Sears et al.
Hoover et al., "Techniques for Inhibiting Tumor Metastases", Cancer, vol. 35, Jan. 1975, p. 512.
Gasic et al., "Anti-Metastatic Effect of Aspirin", The Lancet, Oct. 28, 1972.
Honn et al., "Prostacyclin and Thromboxanes Implications for Their Role in Tumor Cell Metastasis", Biochemical Pharmacology, Vo. 32, No. 1, pp. 1-11, 1983.
Bhat et al., "Structures and Stereochemistry of New Labdane Diterpenoids from Coleus Forskohlii Briq..sup.1 ", Tetrahedron Letters, No. 19, pp. 1669-1672, 1977.
Adnot et al., "Forskolin (A Powerful Inhibit or of Human Platelet Aggregation)", Biochemical Pharmacology, vol. 31, No. 24, pp. 4074-4076, 1982.
Bhat et al., "The Antihypertensive and Positive Inotropic Diterpene Forskolin: Effects of Structural Modifications on its Activity", J. Med. Chem. 26, pp. 486-492, 1983.
de Souza et al., "Forskolin: A Labdane Diterpenoid With Antihypertensive, Positive Inotropic . . . ", Medicinal Research Reviews, vol. 3, No. 2, pp. 201-219 1983.
Agarwal & Parks, "Synergistic Inhibition of Platelet Aggregation by Forskoliln Plus . . . ", Biochemical Pharmacology, vol. 31, No. 22, pp. 3713-3716, 1982.
"Structure-Activity Relationships for Activation of Adenylate Cyclase by the Diterpene Forskolin and its Derivatives", Seamon et al., J. Med. Chem., 1983, 26, pp. 436-439.
Agarwal Kailash C.
Parks, Jr. Robert E.
Brown University Research Foundation
Engellenner Thomas J.
Goldberg Jerome D.
LandOfFree
Treatment of metastasis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of metastasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of metastasis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-505247